JP2005530696A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530696A5
JP2005530696A5 JP2003570852A JP2003570852A JP2005530696A5 JP 2005530696 A5 JP2005530696 A5 JP 2005530696A5 JP 2003570852 A JP2003570852 A JP 2003570852A JP 2003570852 A JP2003570852 A JP 2003570852A JP 2005530696 A5 JP2005530696 A5 JP 2005530696A5
Authority
JP
Japan
Prior art keywords
kit
testing
concentration
less
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003570852A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530696A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/001071 external-priority patent/WO2003072106A2/en
Publication of JP2005530696A publication Critical patent/JP2005530696A/ja
Publication of JP2005530696A5 publication Critical patent/JP2005530696A5/ja
Withdrawn legal-status Critical Current

Links

JP2003570852A 2002-02-27 2003-02-26 物質使用障害を治療するためのチロシンキナーゼ阻害剤の使用方法 Withdrawn JP2005530696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35965102P 2002-02-27 2002-02-27
PCT/IB2003/001071 WO2003072106A2 (en) 2002-02-27 2003-02-26 Use of tyrosine kinase inhibitors for treating substance use disorders

Publications (2)

Publication Number Publication Date
JP2005530696A JP2005530696A (ja) 2005-10-13
JP2005530696A5 true JP2005530696A5 (enExample) 2006-03-09

Family

ID=27766119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003570852A Withdrawn JP2005530696A (ja) 2002-02-27 2003-02-26 物質使用障害を治療するためのチロシンキナーゼ阻害剤の使用方法

Country Status (9)

Country Link
US (1) US20050203098A1 (enExample)
EP (1) EP1490067B1 (enExample)
JP (1) JP2005530696A (enExample)
AT (1) ATE408407T1 (enExample)
AU (1) AU2003209933A1 (enExample)
CA (1) CA2477726A1 (enExample)
DE (1) DE60323613D1 (enExample)
ES (1) ES2314223T3 (enExample)
WO (1) WO2003072106A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20030130297A1 (en) 2001-07-06 2003-07-10 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
EP1684750B1 (en) 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
CN101657446B (zh) 2007-02-13 2013-05-15 Ab科学有限公司 合成作为激酶抑制剂的2-氨基噻唑化合物的方法
CN105974131B (zh) * 2016-06-16 2017-12-26 武汉大学 c‑Kit作为药物成瘾治疗靶点的应用
US20220079950A1 (en) * 2018-12-31 2022-03-17 The Regents Of The University Of California Therapeutic combinations as antidotes for organophosphate exposure
CN112569238A (zh) * 2019-09-30 2021-03-30 武汉大学 伊马替尼及其衍生物与镇痛药联合用药或复方制剂在治疗疼痛中的应用
CN112575073B (zh) * 2019-09-30 2022-10-04 武汉大学 c-Kit作为成瘾诊断及监测标志物的应用
WO2022047289A1 (en) * 2020-08-28 2022-03-03 Emory University Methods of managing cocaine or other drug addictions
CN114573591B (zh) * 2022-04-16 2023-04-25 成都施贝康生物医药科技有限公司 一种取代的吡咯并嘧啶化合物及其应用
CN117461602B (zh) * 2023-10-25 2024-10-25 六合熙诚(北京)信息科技有限公司 一种吗啡成瘾动物模型的构建方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (enExample) * 1992-04-03 1994-06-21 Ciba Geigy Ag

Similar Documents

Publication Publication Date Title
JP2005515404A5 (enExample)
ATE554113T1 (de) Butencopolymere und verfahren zu ihrer herstellung
ATE541843T1 (de) 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten
ATE489469T1 (de) Maize kompositionen mit erhöhtem lysine gehalt und methoden zu deren detektion
ATE347890T1 (de) Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
JP2005530696A5 (enExample)
DE502004011957D1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ITPD20020138A0 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
ATE423166T1 (de) Pflanzliches-öl-stärkepfropfcopolymere und ihre biofaserverbundwerkstoffe und verfahren zu ihrer herstellung
EP1744167A4 (en) SHEET-LIKE SENSOR, METHOD OF MANUFACTURING THE SAME, AND PROBE APPLICATION
JP2005526058A5 (enExample)
DE60220245D1 (de) Integriertes Widerstandselement, Phasenwechsel Speicherelement mit solchem Widerstandselement, und Verfahren zu seiner Herstellung
JP2005515295A5 (enExample)
ITMO20030289A1 (it) Apparati, metodo e articolo.
NL1029360A1 (nl) Gesubstitueerde heteroaryl- en fenylsulfamoylverbindingen.
ATE482193T1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
ATE327981T1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
NL1028519A1 (nl) Gesubstitueerde heteroaryl- en fenylsulfamoylverbindingen.
DE60239493D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
JP2005501564A5 (enExample)
DE602004028125D1 (de) 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
IS8212A (is) Nýjar 8-aza-bísýkló[3.2.1]oktanafleiður og notkunþeirra sem mónóamín-taugaboðefnaendurupptökuhindrar
ATE394394T1 (de) Arylvinylazacycloalkane verbindungen und methoden zu ihrer herstellung und deren verwendung
EP1681727A4 (en) LUMINESCENT SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURE
NO20033998L (no) Fremgangsmate for a bestemme resistivitetsindeksen, som en funksjon av vannmetning, til sten med kompleks porositet